Personalis : Management Change - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT ... | June 14, 2023
Source: marketscreener.com
📰 Kenneth Widder News
Kenneth Widder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kenneth Widder. Real-time updates on events, politics, business and more.
Santen and Sydnexis execute an exclusive licensing agreement for SYD-101, a novel investigational treatment for progressive childhood myopia
Santen SA, a specialist in ophthalmology, and Sydnexis Inc., a biopharmaceutical company focused on the development of therapies for the treatment of progressive myopia, announce the signing of an exclusive licensing agreement for SYD-101, Sydnexis’ investigational proprietary low dose atropine formulation, for ...
Source: pharmiweb.com